$2.99 -0.03 (-0.99%)
11/25/2009 4:00 PM

Vical, Inc. (VICL)

CAPS Rating: 2 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Featured Broker Partners